Fisiología
Department
Institute Catalá Oncología
Barcelona, EspañaPublications in collaboration with researchers from Institute Catalá Oncología (3)
2016
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433